Diabetes Drug Mounjaro Helps Overweight Adults Lose Significant Weight in New Study

The diabetes drug Mounjaro, which contains tirzepatide, helped participants lose around 25% of their body weight when combined with diet and exercise.
In the study, those who took Mounjaro lost around 60 pounds on average, while a placebo group initially lost but then regained some weight.
Mounjaro works by influencing appetite through hormone receptors that regulate hunger and fullness.
Tirzepatide is under FDA review for potential approval as an obesity treatment, with a decision expected by late 2023.
Common side effects of Mounjaro include nausea, diarrhea, and constipation.